US biotech Outlook Therapeutics revealed that the US Food and Drug Administration (FDA) has approved Lytenava ...

Shares of US biotech Forte Biosciences shot up nearly 40% to $76.40 in early trading, on the news of a takeover bid from ...

Cambridge, USA-based biotech Oak Hill Bio this morning announced plans to go public via a combination with RA Capital-backed ...

UK-based Novogene Europe, a multiomics research services partner, today announced that it has expanded its single-cell RNA ...

Among significant news last week, Halozyme Therapeutics struck a license agreement for its INCA033989 with fellow USA-based ...

Sanofi has announced changes to its executive committee, as the French pharma major streamlines senior leadership under chief ...

Spanish medical dermatology company Almirall (BME: ALM) has reported first-half 2026 net sales of 602.7 million euros ($687.1 ...

US pharma major Johnson & Johnson has reported positive top-line Phase III data showing that a dual bispecific antibody ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) today announced recommendations for the approval of ...

UK gene therapy company EpilepsyGTx has named Teresa Nunes as its chief medical officer, tasking her with steering lead ...

US president Donald Trump has set a countdown for tariffs on imported generic medicines, ending an exemption that had ...

US pharma majors Gilead Sciences and Merck & Co have reported detailed Phase III data showing that their investigational once ...